{
    "code": "01007682",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01007682",
    "time": "2020-02-25 01:59:27",
    "許可證字號": "衛署藥製字第007682號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "113\/05\/25",
    "發證日期": "64\/10\/14",
    "許可證種類": "製　劑",
    "舊證字號": "00000000",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHY00100768201",
    "中文品名": "&quot;利達&quot; 得舒爽注射液４毫克\/毫升",
    "英文品名": "DEXASON INJECTION 4MG\/ML &quot;LITA&quot;",
    "適應症": "風濕性關節炎、風濕熱、紅斑性狼瘡等之膠原病、強直性脊椎炎、骨關節炎、痛風性關節炎等之關節炎症、支氣管氣喘等過敏性疾患",
    "劑型": "270注射劑",
    "包裝": "1毫升 100支以下盒裝小瓶 10毫升 100支以下盒裝小瓶",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "05限由醫師使用",
    "藥品分類": "",
    "主製造廠": {
        "限制項目": "01國　產",
        "申請商名稱": "0701010200  利達製藥股份有限公司",
        "申請商地址": "台中市大甲區中山路一段９０６號",
        "主製造廠": ""
    },
    "CCC號列": "30043200002 其他醫藥製劑，含有腎上腺皮質類固醇荷爾蒙及其衍生物或結構式類似者Other medicaments, containing corticosteroid hormones, their derivatives or structural analogues",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "6804000640",
            "成分名稱": "DEXAMETHASONE SODIUM PHOSPHATE",
            "含量描述": "",
            "含量": "4.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "01007682-106-05-03.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01007682&Seq=004&Type=9"
        },
        {
            "title": "DXV 瓶標範本-2014-08-22.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01007682&Seq=003&Type=9"
        },
        {
            "title": "01007682標籤-106-05-03.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01007682&Seq=002&Type=8"
        },
        {
            "title": "DXV盒標籤範本-2014-08-22.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01007682&Seq=001&Type=8"
        }
    ]
}